Tower Research Capital LLC (Trc) Galera Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$1.48 - $2.68 $734 - $1,329	-496 Reduced 2.78%	17,323 $44,000
Q4 2022 Feb 10, 2023	BUY	$1.34 - $1.78 $10,166 - $13,504	7,587 Added 74.15%	17,819 $27,000
Q3 2022 Nov 10, 2022	BUY	$1.15 - $2.1 $11,766 - $21,487	10,232 New	10,232 $18,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.39 $1,631 - $3,145	-1,316 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.01 - $4.19 $2,645 - $5,514	1,316 New	1,316 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $8.28 $2,890 - $18,845	-2,276 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.04 - $10.49 $14,481 - $21,577	2,057 Added 939.27%	2,276 $19,000
Q2 2021 Aug 16, 2021	SELL	$6.08 - $10.44 $10,050 - $17,257	-1,653 Reduced 88.3%	219 $2,000
Q1 2021 May 17, 2021	BUY	$8.35 - $12.39 $1,052 - $1,561	126 Added 7.22%	1,872 $17,000
Q4 2020 Feb 16, 2021	SELL	$8.02 - $12.81 $53,990 - $86,236	-6,732 Reduced 79.41%	1,746 $18,000
Q3 2020 Nov 16, 2020	BUY	$6.96 - $9.12 $49,158 - $64,414	7,063 Added 499.15%	8,478 $77,000
Q2 2020 Aug 13, 2020	BUY	$7.14 - $14.41 $9,389 - $18,949	1,315 Added 1315.0%	1,415 $10,000
Q1 2020 May 15, 2020	SELL	$5.89 - $17.67 $11,897 - $35,693	-2,020 Reduced 95.28%	100 $1,000
Q4 2019 Feb 07, 2020	BUY	$9.13 - $13.9 $19,355 - $29,468	2,120 New	2,120 $28,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.